UK-US Agree Zero Tariff Deal on Medicines
The UK and US have agreed a three-year deal to maintain 0% tariffs on pharmaceuticals, aiming to boost trade and secure NHS access to new treatments. Read the full details.
Category : Search result: pharmaceutical tariffs
UK-US strike tariff deal on pharmaceuticals
The UK and US agree a major trade deal removing US import taxes on UK drugs for 3 years, while the NHS commits to higher spending on new medicines. Discover the impact.
UK-US agree zero tariff deal on pharmaceuticals
The UK and US have struck a deal to maintain 0% tariffs on medicines for three years, alongside NHS commitments to increase spending on new drugs. Discover the implications for patients and industry.
UK-US Agree Zero-Tariff Pharmaceuticals Deal
The UK and US have finalised a landmark trade agreement to eliminate tariffs on pharmaceutical products. Discover how this deal aims to lower drug costs and boost medical innovation.
NHS drug costs to rise 25% in US trade deal
The NHS will pay 25% more for new medicines under a UK-US trade agreement, costing taxpayers £3bn. The deal secures zero tariffs for UK pharmaceutical exports to America. Discover the full impact.
UK and US agree zero tariff deal on medicines
The UK and US have agreed a three-year deal to maintain 0% import tariffs on pharmaceuticals, aiming to secure NHS access to cutting-edge treatments and boost investment. Read the full details.
UK-US set for zero-tariff pharma deal amid NHS price row
The UK is poised to strike a deal with the US removing tariffs on pharmaceuticals, following warnings of investment cuts. The agreement hinges on the NHS paying more for American medicines. Read the full details.
Canada unveils support for steel and lumber sectors
Canada's PM announces a £285m support package for steel and lumber industries crippled by US tariffs. Discover the new quotas and freight subsidies.
ADHD medication recalled over effectiveness issues
A popular generic ADHD medication is being recalled nationwide after tests showed it may not dissolve properly, failing to deliver the full dose. Patients urged to check their prescriptions.
Trump's Pasta Tariffs Threaten UK Food Prices
Former President Donald Trump's proposed 25% tariff on EU pasta imports could significantly increase food costs for British consumers and disrupt supply chains.
Big Pharma's Tax Breaks: Calls for Transparency Grow
Pharmaceutical giants face mounting pressure to justify massive tax incentives amid concerns over NHS funding and pandemic-era profit surges. Westminster demands clarity on whether public investment delivers fair returns.
UK patients face treatment delays in pharma pricing crisis
A bitter pricing dispute between the UK government and pharmaceutical companies threatens to delay vital new medicines for NHS patients, with industry leaders warning of an escalating crisis.
GSK chief warns UK drug pricing reforms threaten industry
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
Aston Martin profit warning over Trump tariffs
British luxury car manufacturer Aston Martin faces significant financial headwinds from Trump-era tariffs and supply chain issues, prompting profit warnings and strategic reviews.
Trump tariffs threaten Christmas festival cancellations
Traditional Sinterklaas celebrations in Rhinebeck and beyond could be cancelled as Dutch organisers struggle with soaring costs from Trump's aluminium and steel tariffs, putting festive traditions at risk.
Trump's 25% Canada tariffs risk Reagan-era trade war
Donald Trump's proposed 25% tariffs on Canadian goods echo Ronald Reagan's 1980s trade war, risking economic damage and diplomatic fallout between the historic allies.
Trump threatens 25% tariffs on Canadian steel
Former President Donald Trump threatens to reignite trade tensions with a 25% tariff on Canadian steel, risking collateral damage to UK manufacturing and global supply chains.
Krone halts US exports over hidden tariffs
German agricultural machinery manufacturer Krone suspends all US exports, blaming complex 'hidden tariffs' that make American market unprofitable despite strong demand.
Trump pressured AstraZeneca on US drug prices
Exclusive investigation reveals how Donald Trump pressured AstraZeneca to slash US drug prices while keeping UK costs high, exposing stark transatlantic healthcare divide.
Indian pharma execs arrested in cough syrup death scandal
Indian authorities have detained three pharmaceutical executives following an investigation into contaminated cough syrup allegedly responsible for numerous child deaths in Cameroon.
Trump's Pasta Tariffs Threaten Italian Producers
Italian pasta producers face devastating 25% tariffs under Trump's new trade war, threatening centuries-old family businesses and the future of authentic Italian pasta exports to the US market.
Trump Tariffs Threaten NHS Drug Price Crisis
Former President Donald Trump's proposed tariffs could dramatically increase costs for NHS medicines, potentially costing the health service billions and threatening patient care across the UK.
Trump Tariffs Threaten NHS Drug Price Crisis
Exclusive investigation reveals how proposed US import tariffs could send NHS drug costs soaring, potentially creating treatment delays and budget crises for Britain's healthcare system.
NHS drug bill may rise £1bn due to Trump tariffs
Exclusive investigation reveals how potential Trump tariffs could devastate NHS medicine budgets while pharmaceutical giants reconsider UK investments over pricing disputes.
Trump's $17 Trillion Tariff Plan Under Fire
Former President Donald Trump's controversial proposal to impose universal 10% tariffs on all imports could trigger the largest tax increase in modern history, raising serious concerns among economists and trade experts.
Trump's Pfizer Deal Aims to Slash US Drug Prices
Former President Donald Trump announces groundbreaking agreement with Pfizer to slash prescription drug costs, vowing to overhaul US healthcare system if re-elected.
Big Pharma's Legal War Threatens NHS Drug Access
Pharmaceutical giants are launching an unprecedented legal assault against the UK government, threatening NHS access to vital medicines and putting patient care at risk in a battle over drug pricing.
Pfizer sued Medicaid for $105M during COVID vaccine rollout
Pharmaceutical giant Pfizer pursued a staggering $105 million Medicaid reimbursement lawsuit against the Trump administration while seeking regulatory approval for its COVID-19 vaccine, reveals explosive court documents.
Weight-Loss Jabs: The Profit-Driven Health Crisis
Exclusive investigation reveals how drug companies are profiting from body shame through Ozempic and Wegovy injections, while eating disorder experts warn of potentially devastating health consequences.
GSK's Growth Gamble: Walmsley's Steady Hand Faces Test
Five years into her tenure, CEO Emma Walmsley has stabilised GSK's ship, but looming patent cliffs and vaccine market pressures cast shadows over ambitious growth targets.
Page 1 of 4